emerginggrowth.com
B. Riley FBR initiates GALT with a Buy and price target of $11. - EmergingGrowth.com
Miami, FL – February 13, 2019 (EmergingGrowth.com NewsWire) — EmergingGrowth.com, a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth markets and companies, reports on Galectin Therapeutics, Inc. (NYSE: GALT). Galectin Therapeutics initiation details — Buy at B. Riley FBR; tgt $11 (4.46 ) : B. Riley …